01 1Loba biotech GmbH
02 1Sentio BioSciences LLC
01 2Melarsomine Dihydrochloride
01 1Austria
02 1U.S.A
NDC Package Code : 62668-6281
Start Marketing Date : 2010-04-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49405-001
Start Marketing Date : 2017-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1.5kg/1.5kg)
Marketing Category : BULK INGREDIENT
A Melarsomine dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Melarsomine dihydrochloride, including repackagers and relabelers. The FDA regulates Melarsomine dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Melarsomine dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Melarsomine dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Melarsomine dihydrochloride supplier is an individual or a company that provides Melarsomine dihydrochloride active pharmaceutical ingredient (API) or Melarsomine dihydrochloride finished formulations upon request. The Melarsomine dihydrochloride suppliers may include Melarsomine dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Melarsomine dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Melarsomine dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Melarsomine dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Melarsomine dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Melarsomine dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Melarsomine dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Melarsomine dihydrochloride suppliers with NDC on PharmaCompass.
We have 2 companies offering Melarsomine dihydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
